Summary
This 8-K filing by Elevance Health, Inc. (formerly Anthem, Inc.) announces that company officers will be speaking with investors between September 12 and September 29, 2017. During these discussions, the company intends to reaffirm its net income guidance for the full year 2017. The reaffirmed guidance indicates a net income expected to be greater than $10.35 per share, which includes approximately $1.35 per share of net unfavorable items. Excluding these specific items, the company anticipates adjusted net income to be greater than $11.70 per share. This guidance explicitly excludes any adjustment items beyond those already reported in the company's second quarter 2017 earnings release.
Key Highlights
- 1Elevance Health (Anthem, Inc.) reaffirming its full-year 2017 net income guidance to investors.
- 2Full-year 2017 net income guidance projected to be greater than $10.35 per share.
- 3Guidance includes approximately $1.35 per share of net unfavorable items.
- 4Adjusted net income guidance (excluding unfavorable items) expected to be greater than $11.70 per share.
- 5Guidance does not incorporate any new adjustment items beyond those disclosed in Q2 2017 earnings.
- 6The disclosure is made under Regulation FD and is not considered 'filed' for Section 18 purposes.
- 7The document includes a standard 'forward-looking statements' disclaimer detailing various risks and uncertainties.